BUNAZOSIN HCL

Bunazosin hydrochloride shares identical ocular hypotensive effects with good tolerability. Side effects include mild burning, blurred vision, or dizziness. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 0e9f6d114341 Category: Tag:

Product Description


Mechanism of action

Bunazosin hydrochloride is the water-soluble salt form of bunazosin with identical -antagonist activity. It provides enhanced stability and more predictable solubility for experimental use.

Benefits and advantages

Used in vascular pharmacology, ophthalmic -blockade studies, smooth-muscle tone research, adrenergic-mapping assays and salt-form comparison studies.

Side effects and risks

Risks include orthostatic hypotension, dizziness, nasal congestion and mild cardiac effects. Handle with vascular-active compound precautions.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C19H28ClN5O3

Molecular Weight

409.9 g/mol

CAS Number

52712-76-2

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

bunazosin hydrochloride; 52712-76-2; Detantol; Bunazosin HCl; E-643

IUPAC/Chemical Name

1-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-1,4-diazepan-1-yl]butan-1-one;hydrochloride

InChl Key

NBGBEUITCPENLJ-UHFFFAOYSA-N

InChl Code

InChI=1S/C19H27N5O3.ClH/c1-4-6-17(25)23-7-5-8-24(10-9-23)19-21-14-12-16(27-3)15(26-2)11-13(14)18(20)22-19;/h11-12H,4-10H2,1-3H3,(H2,20,21,22);1H

References

https://pubchem.ncbi.nlm.nih.gov/compound/115305;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download